Work

Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer

Year: 2010

Type: article

Study design: Clinical Trial

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-010-1252-x

Authors: Elaine T. Lam, Jessie L.- S. Au, Gregory A. Otterson, M. Guillaume Wientjes, Ling Chen, Tong Shen, Yong Wei, Xiaobai Li, Tanios Bekaii-Saab, Anthony J. Murgo, Rhonda R. Jensen, Michael Grever, Miguel A. Villalona-Calero

Institutions: The Ohio State University, National Cancer Institute, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institute for Health and Care Research, National Institutes of Health, National Cancer Institute

Awards: Chemoresistance in Renal Cell Cancer, Phase I Trials of Anti-Cancer Agents

OpenAlex ID: W2013472383

FWCI: 1.261

Cites: 43

Cited by: 23

Related to: 10